Neal S. Shah, MD
Show Description +
Dr. Shah explains the longitudinal quantitative ultra-widefield retinal leakage assessment after a single axitinib hydrogel injection (OTX-TKI, Ocular Therapeutix) from the HELIOS trial for diabetic retinopathy.
Posted: 5/16/2025
Neal S. Shah, MD
Dr. Shah explains the longitudinal quantitative ultra-widefield retinal leakage assessment after a single axitinib hydrogel injection (OTX-TKI, Ocular Therapeutix) from the HELIOS trial for diabetic retinopathy.
Posted: 5/16/2025
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ARVO: 2025.
Please log in to leave a comment.